IDEXX Laboratories, Inc.
Hedge Funds Holdings
Last updated:
IDEXX Laboratories, Inc.‘s stocks are currently a part of 993 hedge funds’ portfolios, which represents 82.92% of the total amount of its stocks outstanding. This makes up a total of 71.78M shares of IDEXX Laboratories, Inc.. Compared to the previous quarter, the number grew by 0.27% or 195.78K shares more. As for the holding position changes, 35.15% (349) of current hedge fund investors increased the number of shares held, 39.68% (394) of current holders sold a part of the shares held, and 14.4% (143) closed the holdings completely. 79 hedge funds are new holders of IDEXX Laboratories, Inc. stock in Q1 2022, it is 7.96% of total holders.
Hedge funds holding IDEXX Laboratories (Q2 2017 – Q1 2022)
| Q2 2017 | 577 |
|---|---|
| Q3 2017 | 569 |
| Q4 2017 | 606 |
| Q1 2018 | 638 |
| Q2 2018 | 656 |
| Q3 2018 | 688 |
| Q4 2018 | 662 |
| Q1 2019 | 676 |
| Q2 2019 | 706 |
| Q3 2019 | 707 |
| Q4 2019 | 747 |
| Q1 2020 | 733 |
| Q2 2020 | 785 |
| Q3 2020 | 833 |
| Q4 2020 | 949 |
| Q1 2021 | 988 |
| Q2 2021 | 1,006 |
| Q3 2021 | 1,030 |
| Q4 2021 | 1,079 |
| Q1 2022 | 993 |
Hedge funds changes in IDEXX Laboratories positions (Q2 2017 – Q1 2022)
| Q2 2017 | 86 | 195 | 215 | 35 | 46 |
|---|---|---|---|---|---|
| Q3 2017 | 46 | 178 | 234 | 47 | 64 |
| Q4 2017 | 79 | 159 | 262 | 41 | 65 |
| Q1 2018 | 95 | 161 | 276 | 53 | 53 |
| Q2 2018 | 68 | 213 | 254 | 48 | 73 |
| Q3 2018 | 83 | 216 | 267 | 42 | 80 |
| Q4 2018 | 83 | 227 | 241 | 106 | 5 |
| Q1 2019 | 88 | 243 | 223 | 70 | 52 |
| Q2 2019 | 96 | 205 | 282 | 58 | 65 |
| Q3 2019 | 67 | 238 | 257 | 63 | 82 |
| Q4 2019 | 106 | 240 | 250 | 52 | 99 |
| Q1 2020 | 84 | 239 | 292 | 93 | 25 |
| Q2 2020 | 114 | 248 | 293 | 55 | 75 |
| Q3 2020 | 97 | 279 | 301 | 49 | 107 |
| Q4 2020 | 172 | 312 | 317 | 50 | 98 |
| Q1 2021 | 106 | 352 | 366 | 58 | 106 |
| Q2 2021 | 103 | 321 | 379 | 74 | 129 |
| Q3 2021 | 99 | 333 | 387 | 70 | 141 |
| Q4 2021 | 144 | 339 | 406 | 82 | 108 |
| Q1 2022 | 79 | 349 | 394 | 143 | 28 |
Hedge funds changes in IDEXX Laboratories stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 19,858,000 | 26,905,000 |
|---|---|---|
| Q3 2017 | 25,927,000 | 56,028,334,000 |
| Q4 2017 | 17,016,527,000 | 59,032,261,000 |
| Q1 2018 | 59,021,341,000 | 28,241,000 |
| Q2 2018 | 46,635,000 | 43,170,000 |
| Q3 2018 | 52,844,000 | 52,377,000 |
| Q4 2018 | 35,026,000 | 42,334,000 |
| Q1 2019 | 37,945,000 | 69,537,000 |
| Q2 2019 | 25,825,000 | 78,827,000 |
| Q3 2019 | 33,485,000 | 86,402,000 |
| Q4 2019 | 28,101,000 | 71,059,000 |
| Q1 2020 | 30,263,000 | 39,228,000 |
| Q2 2020 | 53,611,000 | 58,704,000 |
| Q3 2020 | 68,221,000 | 480,065,222,000 |
| Q4 2020 | 63,686,000 | 876,105,705,000 |
| Q1 2021 | 78,593,000 | 5,037,186,033,000 |
| Q2 2021 | 258,146,942,000 | 5,972,226,896,000 |
| Q3 2021 | 205,343,279 | 4,730,286,333,000 |
| Q4 2021 | 144,031,000 | 4,793,198,682,000 |
| Q1 2022 | 111,222,000 | 177,047,000 |